Pharmacokinetics and Tolerability of a Single Dose of Semaglutide, a Human Glucagon-Like Peptide-1 Analog, in Subjects With and Without Renal Impairment

BACKGROUND: The pharmacokinetics and tolerability of semaglutide, a once-weekly human glucagon-like peptide-1 analog in development for the treatment of type 2 diabetes mellitus, were investigated in subjects with/without renal impairment (RI). METHODS: Fifty-six subjects, categorized into renal fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Marbury, Thomas C., Flint, Anne, Jacobsen, Jacob B., Derving Karsbøl, Julie, Lasseter, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648736/
https://www.ncbi.nlm.nih.gov/pubmed/28349386
http://dx.doi.org/10.1007/s40262-017-0528-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648736/
https://www.ncbi.nlm.nih.gov/pubmed/28349386
http://dx.doi.org/10.1007/s40262-017-0528-2

Ejemplares similares